Two Sigma Securities’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.73K | Buy |
+17,818
| New | +$7.73K | ﹤0.01% | 1325 |
|
|
2024
Q4 | – | Sell |
-10,120
| Closed | -$14K | – | 2242 |
|
|
2024
Q3 | $14K | Buy |
10,120
+7,679
| +315% | +$10.6K | ﹤0.01% | 1305 |
|
|
2024
Q2 | $14.4K | Buy |
2,441
+1,590
| +187% | +$9.39K | ﹤0.01% | 1324 |
|
|
2024
Q1 | $9.98K | Buy |
+851
| New | +$9.98K | ﹤0.01% | 1265 |
|
|
2023
Q4 | – | Sell |
-639
| Closed | -$8.61K | – | 2082 |
|
|
2023
Q3 | $8.61K | Buy |
+639
| New | +$8.61K | ﹤0.01% | 1182 |
|
|
2022
Q4 | – | Sell |
-734
| Closed | -$18K | – | 1991 |
|
|
2022
Q3 | $18K | Buy |
734
+455
| +163% | +$11.2K | ﹤0.01% | 1101 |
|
|
2022
Q2 | $15K | Buy |
279
+128
| +85% | +$6.88K | ﹤0.01% | 1035 |
|
|
2022
Q1 | $11K | Buy |
+151
| New | +$11K | ﹤0.01% | 1043 |
|
|
2020
Q3 | – | Sell |
-80
| Closed | -$10K | – | 948 |
|
|
2020
Q2 | $10K | Buy |
+80
| New | +$10K | ﹤0.01% | 536 |
|
|
2019
Q2 | – | Sell |
-75
| Closed | -$13K | – | 1347 |
|
|
2019
Q1 | $13K | Buy |
+75
| New | +$13K | ﹤0.01% | 751 |
|
|
2018
Q4 | – | Sell |
-45
| Closed | -$29K | – | 1684 |
|
|
2018
Q3 | $29K | Buy |
45
+38
| +543% | +$24.5K | ﹤0.01% | 1030 |
|
|
2018
Q2 | $14K | Buy |
7
+4
| +133% | +$8K | ﹤0.01% | 989 |
|
|
2018
Q1 | $8K | Sell |
3
-6
| -67% | -$16K | ﹤0.01% | 1108 |
|
|
2017
Q4 | $39K | Buy |
9
+5
| +125% | +$21.7K | ﹤0.01% | 861 |
|
|
2017
Q3 | $30K | Buy |
+4
| New | +$30K | ﹤0.01% | 740 |
|
|
2017
Q1 | – | Sell |
-3
| Closed | -$23K | – | 1113 |
|
|
2016
Q4 | $23K | Buy |
+3
| New | +$23K | 0.01% | 648 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | -$25K | – | 516 |
|
|
2016
Q1 | $25K | Buy |
+1
| New | +$25K | 0.03% | 231 |
|